Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Abstract Background Single-nucleotide polymorphisms (SNPs) identified by genome-wide association studies only explain part of the heritability of Alzheimer’s disease (AD). Epistasis has been considered as one of the main causes of “missing heritability” in AD. Methods We performed genome-wide epista...
Main Authors: | Hui Wang, David A. Bennett, Philip L. De Jager, Qing-Ye Zhang, Hong-Yu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-021-00794-8 |
Similar Items
-
Polygenic Score Models for Alzheimer’s Disease: From Research to Clinical Applications
by: Xiaopu Zhou, et al.
Published: (2021-03-01) -
The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia
by: Shinya Tasaki, et al.
Published: (2018-10-01) -
Shared Genetic Etiology between Alzheimer’s Disease and Blood Levels of Specific Cytokines and Growth Factors
by: Robert J. van der Linden, et al.
Published: (2021-06-01) -
Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
by: Dimitrios Vlachakis, et al.
Published: (2021-06-01) -
Association of genetic and behavioral characteristics with the onset of diabetes
by: Carmen D. Ng, et al.
Published: (2019-10-01)